Xenin: Difference between revisions
Jump to navigation
Jump to search
(Undid revision 807734720 by 100.15.1.144 (talk) Apparent vandalism.) |
imported>Rodw m (Disambiguating links to Glycemia (link changed to Blood sugar) using DisamAssist.) |
||
| Line 39: | Line 39: | ||
Proxenin is the [[protein precursor|precursor]] to xenin. It is a 35-amino acid polypeptide. Like xenin, its amino acid sequence exactly matches the N-terminus of [[coatomer subunit alpha]].<ref name="COPA_HUMAN"/> | Proxenin is the [[protein precursor|precursor]] to xenin. It is a 35-amino acid polypeptide. Like xenin, its amino acid sequence exactly matches the N-terminus of [[coatomer subunit alpha]].<ref name="COPA_HUMAN"/> | ||
== As a drug target == | |||
Xenin promotes [[beta-cell]] survival and xenin has been evaluated in [[animal model]]s of [[obesity]] and [[diabetes]] where it has demonstrated an antidiabetic potential.<ref name="Craig_2018">{{cite journal | vauthors = Craig SL, Gault VA, Irwin N | title = Emerging therapeutic potential for xenin and related peptides in obesity and diabetes | journal = Diabetes/metabolism Research and Reviews | volume = 34 | issue = 6 | pages = e3006 | date = September 2018 | pmid = 29633491 | doi = 10.1002/dmrr.3006 }}</ref> In humans, co-administration of xenin-25 and [[gastric inhibitory polypeptide]] (GIP) reduces [[postprandial]] [[Blood sugar|glycemia]] by delaying [[gastric emptying]]. <ref name="Hussain">{{cite journal | vauthors = Hussain MA, Akalestou E, Song WJ | title = Inter-organ communication and regulation of beta cell function | journal = Diabetologia | volume = 59 | issue = 4 | pages = 659–67 | date = April 2016 | pmid = 26791990 | pmc = 4801104 | doi = 10.1007/s00125-015-3862-7 }}</ref> | |||
==References== | ==References== | ||
| Line 46: | Line 50: | ||
{{refbegin}} | {{refbegin}} | ||
* {{cite journal | vauthors = Feurle GE, Pfeiffer A, Schmidt T, Dominguez-Munoz E, Malfertheiner P, Hamscher G | title = Phase III of the migrating motor complex: associated with endogenous xenin plasma peaks and induced by exogenous xenin | journal = Neurogastroenterol. Motil. | volume = 13 | issue = 3 | pages = 237–46 |date=June 2001 | pmid = 11437986 | doi = 10.1046/j.1365-2982.2001.00263.x}} | * {{cite journal | vauthors = Feurle GE, Pfeiffer A, Schmidt T, Dominguez-Munoz E, Malfertheiner P, Hamscher G | title = Phase III of the migrating motor complex: associated with endogenous xenin plasma peaks and induced by exogenous xenin | journal = Neurogastroenterol. Motil. | volume = 13 | issue = 3 | pages = 237–46 |date=June 2001 | pmid = 11437986 | doi = 10.1046/j.1365-2982.2001.00263.x}} | ||
* {{cite journal | vauthors = Feurle GE, Anlauf M, Hamscher G, Arnold R, Klöppel G, Weihe E | title = Xenin-immunoreactive cells and extractable xenin in neuroendocrine tumors of duodenal origin | journal = Gastroenterology | volume = 123 | issue = 5 | pages = 1616–26 |date=November 2002 | pmid = 12404236 | doi = 10.1053/gast.2002.36590}} | * {{cite journal | vauthors = Feurle GE, Anlauf M, Hamscher G, Arnold R, Klöppel G, Weihe E | title = Xenin-immunoreactive cells and extractable xenin in neuroendocrine tumors of duodenal origin | journal = Gastroenterology | volume = 123 | issue = 5 | pages = 1616–26 |date=November 2002 | pmid = 12404236 | doi = 10.1053/gast.2002.36590| url = http://www.gastrojournal.org/article/S0016508502002950/pdf }} | ||
* {{cite journal | vauthors = Feurle GE, Ikonomu S, Partoulas G, Stoschus B, Hamscher G | title = Xenin plasma concentrations during modified sham feeding and during meals of different composition demonstrated by radioimmunoassay and chromatography | journal = Regul. Pept. | volume = 111 | issue = | * {{cite journal | vauthors = Feurle GE, Ikonomu S, Partoulas G, Stoschus B, Hamscher G | title = Xenin plasma concentrations during modified sham feeding and during meals of different composition demonstrated by radioimmunoassay and chromatography | journal = Regul. Pept. | volume = 111 | issue = 1–3 | pages = 153–9 |date=March 2003 | pmid = 12609763 | doi = 10.1016/s0167-0115(02)00281-1}} | ||
* {{cite journal | vauthors = Taylor AI, Irwin N, McKillop AM, Patterson S, Flatt PR, Gault VA | title = Evaluation of the degradation and metabolic effects of the gut peptide xenin on insulin secretion, glycaemic control and satiety | journal = J. Endocrinol. | volume = 207 | issue = 1 | pages = 87–93 |date=October 2010 | pmid = 20631047 | doi = 10.1677/JOE-10-0085 }} | * {{cite journal | vauthors = Taylor AI, Irwin N, McKillop AM, Patterson S, Flatt PR, Gault VA | title = Evaluation of the degradation and metabolic effects of the gut peptide xenin on insulin secretion, glycaemic control and satiety | journal = J. Endocrinol. | volume = 207 | issue = 1 | pages = 87–93 |date=October 2010 | pmid = 20631047 | doi = 10.1677/JOE-10-0085 }} | ||
* {{cite journal | vauthors = Leckstrom A, Kim ER, Wong D, Mizuno TM | title = Xenin, a gastrointestinal peptide, regulates feeding independent of the melanocortin signaling pathway | journal = Diabetes | volume = 58 | issue = 1 | pages = 87–94 |date=January 2009 | pmid = 18984739 | pmc = 2606897 | doi = 10.2337/db08-0260 }} | * {{cite journal | vauthors = Leckstrom A, Kim ER, Wong D, Mizuno TM | title = Xenin, a gastrointestinal peptide, regulates feeding independent of the melanocortin signaling pathway | journal = Diabetes | volume = 58 | issue = 1 | pages = 87–94 |date=January 2009 | pmid = 18984739 | pmc = 2606897 | doi = 10.2337/db08-0260 }} | ||
Latest revision as of 21:42, 16 December 2018
This article includes a list of references, but its sources remain unclear because it has insufficient inline citations. (February 2008) (Learn how and when to remove this template message) |
| Coatomer subunit alpha | |
|---|---|
| Identifiers | |
| Symbol | COPA |
| RefSeq | NP_001091868 |
| UniProt | P53621 |
| Other data | |
| Locus | Chr. 1 q23.2 |
Xenin is a peptide hormone produced by a subpopulation of chromogranin A-positive endocrine cells in the mucous membrane of the duodenum. The peptide has been found in humans, dogs, pigs, rats, and rabbits.
In humans, xenin circulates in the blood plasma.[1] There is a relationship between peaks of xenin concentration in the plasma and the third phase of the Migrating Motor Complex. For example, infusion of synthetic xenin in fasting volunteers will cause phase III activity. After a meal (the 'postprandial state'), infusion of xenin increases both frequency and the percentage of aborally propagated contractions. In higher concentrations xenin stimulates exocrine pancreatic secretion and inhibits the gastrin-stimulated secretion of acid in dogs. Xenin is also produced in neuroendocrine tumors of the duodenal mucosa.
In vitro, xenin interacts with the neurotensin receptor 1.
Structure and sequence
Xenin is a 25-amino acid polypeptide. The amino acid sequence of xenin is identical to the N-terminal end of cytoplasmic coatomer subunit alpha,[2] from which xenin can be cleaved by aspartic proteases. Xenin is structurally related to the amphibian peptide xenopsin and to the neuropeptide neurotensin.
Proxenin
Proxenin is the precursor to xenin. It is a 35-amino acid polypeptide. Like xenin, its amino acid sequence exactly matches the N-terminus of coatomer subunit alpha.[2]
As a drug target
Xenin promotes beta-cell survival and xenin has been evaluated in animal models of obesity and diabetes where it has demonstrated an antidiabetic potential.[3] In humans, co-administration of xenin-25 and gastric inhibitory polypeptide (GIP) reduces postprandial glycemia by delaying gastric emptying. [4]
References
- ↑ Feurle GE, Hamscher G, Kusiek R, Meyer HE, Metzger JW (November 1992). "Identification of xenin, a xenopsin-related peptide, in the human gastric mucosa and its effect on exocrine pancreatic secretion". J. Biol. Chem. 267 (31): 22305–9. PMID 1429581.
- ↑ 2.0 2.1 UniProtKB/Swiss-Prot entry P53621 COPA_HUMAN
- ↑ Craig SL, Gault VA, Irwin N (September 2018). "Emerging therapeutic potential for xenin and related peptides in obesity and diabetes". Diabetes/metabolism Research and Reviews. 34 (6): e3006. doi:10.1002/dmrr.3006. PMID 29633491.
- ↑ Hussain MA, Akalestou E, Song WJ (April 2016). "Inter-organ communication and regulation of beta cell function". Diabetologia. 59 (4): 659–67. doi:10.1007/s00125-015-3862-7. PMC 4801104. PMID 26791990.
Further reading
- Feurle GE, Pfeiffer A, Schmidt T, Dominguez-Munoz E, Malfertheiner P, Hamscher G (June 2001). "Phase III of the migrating motor complex: associated with endogenous xenin plasma peaks and induced by exogenous xenin". Neurogastroenterol. Motil. 13 (3): 237–46. doi:10.1046/j.1365-2982.2001.00263.x. PMID 11437986.
- Feurle GE, Anlauf M, Hamscher G, Arnold R, Klöppel G, Weihe E (November 2002). "Xenin-immunoreactive cells and extractable xenin in neuroendocrine tumors of duodenal origin". Gastroenterology. 123 (5): 1616–26. doi:10.1053/gast.2002.36590. PMID 12404236.
- Feurle GE, Ikonomu S, Partoulas G, Stoschus B, Hamscher G (March 2003). "Xenin plasma concentrations during modified sham feeding and during meals of different composition demonstrated by radioimmunoassay and chromatography". Regul. Pept. 111 (1–3): 153–9. doi:10.1016/s0167-0115(02)00281-1. PMID 12609763.
- Taylor AI, Irwin N, McKillop AM, Patterson S, Flatt PR, Gault VA (October 2010). "Evaluation of the degradation and metabolic effects of the gut peptide xenin on insulin secretion, glycaemic control and satiety". J. Endocrinol. 207 (1): 87–93. doi:10.1677/JOE-10-0085. PMID 20631047.
- Leckstrom A, Kim ER, Wong D, Mizuno TM (January 2009). "Xenin, a gastrointestinal peptide, regulates feeding independent of the melanocortin signaling pathway". Diabetes. 58 (1): 87–94. doi:10.2337/db08-0260. PMC 2606897. PMID 18984739.
| Stub icon | This biochemistry article is a stub. You can help Wikipedia by expanding it. |
.svg){kind=link}